- Home
- MSEX vs XNCR Comparison
MSEX vs XNCR Comparison
Compare MSEX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSEX
- XNCR
- Stock Information
- Founded
- MSEX 1897
- XNCR 1997
- Country
- MSEX United States
- XNCR United States
- Employees
- MSEX N/A
- XNCR N/A
- Industry
- MSEX Water Supply
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- MSEX Utilities
- XNCR Health Care
- Exchange
- MSEX Nasdaq
- XNCR Nasdaq
- Market Cap
- MSEX 963.9M
- XNCR 1.1B
- IPO Year
- MSEX N/A
- XNCR 2013
- Fundamental
- Price
- MSEX $54.63
- XNCR $13.81
- Analyst Decision
- MSEX Buy
- XNCR Buy
- Analyst Count
- MSEX 3
- XNCR 11
- Target Price
- MSEX $61.67
- XNCR $24.20
- AVG Volume (30 Days)
- MSEX 150.0K
- XNCR 1.5M
- Earning Date
- MSEX 10-31-2025
- XNCR 11-06-2025
- Dividend Yield
- MSEX 2.48%
- XNCR N/A
- EPS Growth
- MSEX 3.71
- XNCR N/A
- EPS
- MSEX 2.39
- XNCR N/A
- Revenue
- MSEX $194,822,000.00
- XNCR $146,929,000.00
- Revenue This Year
- MSEX $4.27
- XNCR $22.09
- Revenue Next Year
- MSEX $8.65
- XNCR N/A
- P/E Ratio
- MSEX $23.01
- XNCR N/A
- Revenue Growth
- MSEX 6.24
- XNCR N/A
- 52 Week Low
- MSEX $44.17
- XNCR $6.92
- 52 Week High
- MSEX $70.73
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- MSEX 46.13
- XNCR 54.56
- Support Level
- MSEX $44.94
- XNCR $12.17
- Resistance Level
- MSEX $62.18
- XNCR $15.50
- Average True Range (ATR)
- MSEX 2.74
- XNCR 1.10
- MACD
- MSEX -0.86
- XNCR -0.16
- Stochastic Oscillator
- MSEX 58.78
- XNCR 45.60
About MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.